1. Iron metabolism in colorectal cancer: a balancing act

   • Diogo Estêvão
   • Miguel da Cruz-Ribeiro
   • Tânia B. da Cruz

   Review Open access 05 June 2023 Pages: 1545 - 1558

   

2. Predictive genomic biomarkers of therapeutic effects in renal cell carcinoma

   • Weijie Yan
   • Naiqiao Hou
   • Wei Zhai

   Review 24 May 2023 Pages: 1559 - 1575

3. Roles of NRF2 in DNA damage repair

   • Jiale Li
   • Chang Xu
   • Qiang Liu

   Review 26 June 2023 Pages: 1577 - 1593

   

4. Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma

   • Yiwen Chen
   • Yuhang Zhou
   • Kang He

   Review 06 July 2023 Pages: 1595 - 1604

   

5. Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy

   • Jaewang Lee
   • Jong-Lyel Roh

   Review 12 July 2023 Pages: 1605 - 1623

   

6. TGF-β-p-STAT1-LAIR2 axis has a “self-rescue” role for exhausted CD8⁺ T cells in hepatocellular carcinoma

   • Banglun Pan
   • Zengbin Wang
   • Nanhong Tang

   Research 24 May 2023 Pages: 1625 - 1644

   

7. Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma

   • Xiaotong Yang
   • Zhengyan Zhang
   • Jing Xue

   Research 01 June 2023 Pages: 1645 - 1658

   

8. Methionine-producing tumor micro(be) environment fuels growth of solid tumors

   • Alexis A. Vega
   • Erin A. Marshall
   • Wan L. Lam

   Research Open access 15 June 2023 Pages: 1659 - 1673

   

9. LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing

   • Huan Deng
   • Jingwang Gao
   • Bo Wei

   Research 24 June 2023 Pages: 1675 - 1690

   

10. Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer

    • Guangyu Chen
    • Yueze Liu
    • Yupei Zhao

    Research 11 July 2023 Pages: 1691 - 1708

    

11. Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia

    • Yanxin Chen
    • Zhengjun Wu
    • Jianda Hu

    Research 24 July 2023 Pages: 1709 - 1724

    

12. Apo10 and TKTL1 in blood macrophages as biomarkers for differentiating lung cancer from benign lung lesions: a comparative study with conventional biomarkers

    • Chuanbo Xie
    • Shuqing Wang
    • Musheng Zeng

    Brief Report 28 June 2023 Pages: 1725 - 1729

    

13. Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer

    • Shuying He
    • Wen Song
    • Liang Peng

    Research Open access 05 July 2023 Pages: 1731 - 1746

    

14. Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK

    • Weihua Liu
    • Yu Zhao
    • Zhiguo Chen

    Research 07 July 2023 Pages: 1747 - 1762

    

15. Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex

    • Qiqi Shi
    • Bo Yu
    • Haizhong Feng

    Research 19 July 2023 Pages: 1763 - 1775

    

16. CircGLIS3 inhibits thyroid cancer invasion and metastasis through miR-146b-3p/AIF1L axis

    • Siting Cao
    • Yali Yin
    • Haipeng Xiao

    Research 23 August 2023 Pages: 1777 - 1789

    

17. Vimentin promotes glioma progression and maintains glioma cell resistance to oxidative phosphorylation inhibition

    • Yu’e Liu
    • Shu Zhao
    • Kaijun Zhao

    Research 30 August 2023 Pages: 1791 - 1806

    

18. Targeted CRISPR activation and knockout screenings identify novel doxorubicin transporters

    • Yufeng Li
    • Minkang Tan
    • Baoxu Pang

    Research Open access 31 July 2023 Pages: 1807 - 1820

    

19. miR-4739 promotes epithelial-mesenchymal transition and angiogenesis in “driver gene-negative” non-small cell lung cancer via activating the Wnt/β-catenin signaling

    • Wenjian Cen
    • Qin Yan
    • Neng Jiang

    Research 27 July 2023 Pages: 1821 - 1835

    

20. Survivin degradation by bergenin overcomes pemetrexed resistance

    • Xiaoying Li
    • Qi Liang
    • Wei Li

    Research 05 August 2023 Pages: 1837 - 1853

    

21. Triggering pyroptosis enhances the antitumor efficacy of PARP inhibitors in prostate cancer

    • Ao Tian
    • Tingyu Wu
    • Weiliang Xia

    Research 23 August 2023 Pages: 1855 - 1870

    

22. Correction: Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity

    • Yi Yang
    • Siqi Wang
    • Yanxin Li

    Correction 16 October 2023 Pages: 1871 - 1872

    

23. Publisher Correction to: RETRACTED ARTICLE: Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN

    • Bin Wang
    • Zhong-Hua Wu
    • Ming Li

    Publisher Correction 03 December 2023 Pages: 1873 - 1873

24. Retraction Note: IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling

    • Tian-Hao Li
    • Bang-Bo Zhao
    • Wei-Bin Wang

    Retraction Note Open access 30 October 2023 Pages: 1875 - 1875